Personalized approach in the treatment of thyroid cancer: A review
The main goal is to improve treatment outcomes of disseminated inoperable thyroid cancer through a personalized choice of targeted agents. Considering gene mutations in drug choice will further improve the survival of patients with rare mutations. Despite the small sample of patients, mutation detec...
Main Author: | Zamira Ah.-G. Radzhabova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ZAO "Consilium Medicum"
2022-08-01
|
Series: | Consilium Medicum |
Subjects: | |
Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/109884/pdf |
Similar Items
-
Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
by: Markus Eszlinger, et al.
Published: (2023-01-01) -
Nuevas mutaciones asociadas a la enfermedad de Hirschsprung
by: Marta Lorente-Ros, et al.
Published: (2020-10-01) -
RET mutations in a large indian family with medullary thyroid carcinoma
by: D M Mahesh, et al.
Published: (2014-01-01) -
An Introduction to Managing Medullary Thyroid Cancer
by: de Groot Jan, et al.
Published: (2006-07-01) -
RET fusion mutation detected by re-biopsy 7 years after initial cytotoxic chemotherapy: A case report
by: Kei Morikawa, et al.
Published: (2022-11-01)